metastatic melanoma patient Recently Published Documents

Abstract 422: Sequential targeted therapy and immunotherapy of a BRAF positive metastatic melanoma patient with BRAF inhibitor vemurafenib, MEK inhibitor cobimetnib and a novel PD-1 antibody Sintilimab

10.1158/1538-7445.am2021-422 ◽

2021 ◽

Author(s):

Yu Zhang ◽

Xiaomo Li ◽

Tonghui Ma ◽

Baoshan Cao

Keyword(s):

Targeted Therapy ◽

Metastatic Melanoma ◽

Melanoma Patient ◽

Braf Inhibitor ◽

Mek Inhibitor ◽

Abstract 1513: A case study investigation into the role of CD4+ tumor-infiltrating lymphocytes in a metastatic melanoma patient with a complete response to adoptive cell therapy

10.1158/1538-7445.am2021-1513 ◽

2021 ◽

Author(s):

MacLean Hall ◽

Pat Innamarato ◽

Amy Mackay ◽

Holly Branthoover ◽

Alex Alfaro ◽

...

Keyword(s):

Cell Therapy ◽

Metastatic Melanoma ◽

Melanoma Patient ◽

Adoptive Cell Therapy ◽

Tumor Infiltrating Lymphocytes ◽

Complete Response ◽

Infiltrating Lymphocytes

Sarcoid-like reaction in a BRAF V600E-mutated metastatic melanoma patient during treatment with BRAF/MEK-targeted therapy

Melanoma Research ◽

10.1097/cmr.0000000000000735 ◽

2021 ◽

Vol 31 (3) ◽

pp. 272-276

Author(s):

Jens Tijtgat ◽

Julia Katharina Schwarze ◽

Gil Awada ◽

Bart Neyns ◽

Sandrine Aspeslagh

Keyword(s):

Targeted Therapy ◽

Metastatic Melanoma ◽

Melanoma Patient ◽

Braf V600e ◽

Infusion reaction to nivolumab in a metastatic melanoma patient. Safe switch to another anti-programmed death-1: a case report

Melanoma Research ◽

10.1097/cmr.0000000000000710 ◽

2020 ◽

Vol 31 (1) ◽

pp. 88-91

Author(s):

Martín Núñez Abad ◽

Ana Saval Victoria ◽

Milagros Franco La Rosa ◽

Alfonso Berrocal

Keyword(s):

Case Report ◽

Metastatic Melanoma ◽

Melanoma Patient ◽

Infusion Reaction ◽

Programmed Death ◽

Programmed Death 1

PO-1571: Radiomics for prediction of metastatic melanoma patient survival after immunotherapy

Radiotherapy and Oncology ◽

10.1016/s0167-8140(21)01589-9 ◽

2020 ◽

Vol 152 ◽

pp. S851

Author(s):

H. Gabrys ◽

L. Basler ◽

S. Hogan ◽

M. Pavic ◽

M. Bogowicz ◽

...

Keyword(s):

Metastatic Melanoma ◽

Melanoma Patient ◽

Patient Survival ◽

Metastatic melanoma patient outcomes since introduction of immune checkpoint inhibitors in England between 2014 and 2018

International Journal of Cancer ◽

10.1002/ijc.33266 ◽

2020 ◽

Vol 148 (4) ◽

pp. 868-875

Author(s):

Ruth Board ◽

Rebecca Smittenaar ◽

Sarah Lawton ◽

Hanhua Liu ◽

Bukky Juwa ◽

...

Keyword(s):

Metastatic Melanoma ◽

Patient Outcomes ◽

Immune Checkpoint ◽

Melanoma Patient ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

1141P EXCITE: An analysis of the metastatic melanoma patient experience in the advent of novel therapies using health-related social media

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1264 ◽

2020 ◽

Vol 31 ◽

pp. S763

Author(s):

G. Faust ◽

A. Booth ◽

E. Merinopoulou ◽

S. Halhol ◽

H. Tosar ◽

...

Keyword(s):

Social Media ◽

Metastatic Melanoma ◽

Patient Experience ◽

Melanoma Patient ◽

Novel Therapies ◽

Health Related

Metastatic Melanoma Patient–Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-19-1895 ◽

2020 ◽

Vol 26 (14) ◽

pp. 3803-3818 ◽

Cited By ~ 4

Author(s):

Rebecca L. Shattuck-Brandt ◽

Sheau-Chiann Chen ◽

Emily Murray ◽

Christopher Andrew Johnson ◽

Holly Crandall ◽

...

Keyword(s):

Metastatic Melanoma ◽

Melanoma Patient ◽

Single Agent ◽

Mek Inhibition ◽

Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patient

Journal for ImmunoTherapy of Cancer ◽

10.1186/s40425-019-0818-3 ◽

2019 ◽

Vol 7 (1) ◽

Cited By ~ 5

Author(s):

Vincent Pillonel ◽

Vincent Dunet ◽

Andreas F. Hottinger ◽

Gregoire Berthod ◽

Luis Schiappacasse ◽

...

Keyword(s):

Metastatic Melanoma ◽

Melanoma Patient ◽

Spontaneous Resolution ◽

Cns Demyelination